Pfizer #39;s Bextra Faces  #39;Headline Risk #39; Prudential Equity Group maintained a  quot;neutral weight quot; rating on Pfizer (nyse: PFE - news - people ) after Canadian news reports surfaced linking its arthritis drug Celebrex with cardiovascular side effects.